ODYSSEY HEALTH, INC.

Company Odyssey Health, Inc.

Equities

ODYY

US67612C1027

Market Closed - OTC Markets Other stock markets 15:26:48 2024-05-17 EDT			5-day change	1st Jan Change
0.03 ^USD	+3.45%		0.00%	-70.00%

03-22	Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
2023	Oragenics, Inc. completed the acquisition of Assets related to proprietary neurological drug therapies and technologies of Odyssey Health, Inc.	CI

Managers

Managers	Title	Age	Since
Joseph Redmond CEO	Chief Executive Officer	64	17-11-30
Christine Farrell DFI	Director of Finance/CFO	64	19-03-31
Greg Gironda COO	Chief Operating Officer	-	-
Jacob W. VanLandingham PRN	Corporate Officer/Principal	49	19-05-31
Erik Emerson PRN	Corporate Officer/Principal	53	-
Michael Contarino PRN	Corporate Officer/Principal	-	20-02-09

Members of the board

Members of the board	Title	Age	Since
Ricky Richardson BRD	Director/Board Member	62	21-05-05
Joseph Redmond CEO	Chief Executive Officer	64	17-11-30
Jerome Casey BRD	Director/Board Member	65	19-09-19
Jacob W. VanLandingham PRN	Corporate Officer/Principal	49	19-05-31

Shareholders

Name	Equities	%	Valuation
Joseph Redmond 11.95 %	11,516,667	11.95 %	426 117 $
Jonathan D Lutz 4.875 %	4,697,257	4.875 %	173 799 $
John Gandolfo 1.804 %	1,738,792	1.804 %	64 335 $
Christine Farrell 1.424 %	1,372,222	1.424 %	50 772 $
Jerome Casey 1.038 %	1,000,000	1.038 %	37 000 $
Ricky Richardson 0.5189 %	500,000	0.5189 %	18 500 $
Erik Emerson 0.000000 %	0	0.000000 %	- $
Greg Gironda 0.000000 %	0	0.000000 %	- $

Company contact information

Odyssey Health, Inc.

2300 West Sahara Avenue Suite 800 - No. 4012

89102, Las Vegas

+

http://www.odysseyhealthinc.com

address Odyssey Health, Inc.(ODYY)

Sector

This company's sector is not yet available

Stock Market
Equities
ODYY Stock
Company Odyssey Health, Inc.

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW